Literature DB >> 14961779

Implementing the 2-week wait rule for cancer referral in the UK: general practitioners' views and practices.

W Dodds1, M Morgan, C Wolfe, K S Raju.   

Abstract

The 2-week wait rule for cancer referrals became effective in December 2000 for all cancers treated by the National Health Service in the UK. Attainment of this target depends initially on appropriate and timely referral by general practitioners (GPs). General practitioners' views and referral practices under the 2-week wait rule were examined based on a postal survey of 508 GPs in an inner London area (65% response). Data on mode of referral indicated that 90% of GPs used the urgent suspected cancer form, although 38% also sent a letter with further information. General practitioners generally regarded the 2-week wait rule as working well in terms of improving patients' initial access, and 50% thought communication with the hospital had improved. However, 46% expressed some concerns, including problems arising from the different sets of forms required by local cancer networks, the lack of a dedicated referral form for breast cancer, and feelings of a loss of autonomy. General practitioners also acknowledged an element of over-referral under this rule due to the effects of clinical uncertainty and patient pressure and their concerns about increased waiting times for non-target referrals. The survey therefore indicates that GPs are generally positive about the 2-week wait rule but identified some problems of implementation including a need for standardized national cancer referral forms.

Entities:  

Mesh:

Year:  2004        PMID: 14961779     DOI: 10.1111/j.1365-2354.2004.00447.x

Source DB:  PubMed          Journal:  Eur J Cancer Care (Engl)        ISSN: 0961-5423            Impact factor:   2.520


  15 in total

1.  Colonoscopy for colonic wall thickening at computed tomography: a worthwhile pursuit?

Authors:  Brian D Nicholson; Rachel Hyland; Bjorn J Rembacken; Mark Denyer; Mark A Hull; Damian J M Tolan
Journal:  Surg Endosc       Date:  2011-02-27       Impact factor: 4.584

2.  Delays in the diagnosis of lung cancer.

Authors:  Peter M Ellis; Rachel Vandermeer
Journal:  J Thorac Dis       Date:  2011-09       Impact factor: 2.895

3.  Managing the 2-week wait for breast patients.

Authors:  Rishi Singhal; Ravi Marudanayagam; B Balasubramanian; I S Paterson
Journal:  Ann R Coll Surg Engl       Date:  2008-01       Impact factor: 1.891

4.  Risk of incarceration of inguinal hernia among infants and young children awaiting elective surgery.

Authors:  Mohammed Zamakhshary; Teresa To; Jun Guan; Jacob C Langer
Journal:  CMAJ       Date:  2008-11-04       Impact factor: 8.262

5.  Audit of two-week rule referrals for suspected testicular cancer in Cornwall, 2003-2005.

Authors:  Prakash Kumaraswamy; Robert Cox; John S O'Rourke; Robert G Willis
Journal:  Ann R Coll Surg Engl       Date:  2009-02-13       Impact factor: 1.891

6.  Does limiting long-term follow-up for breast cancer allow all referrals to be seen in 2 weeks?

Authors:  S Potter; S Govindarajulu; M Shere; F Braddon; J Turner; A K Sahu; S J Cawthorn
Journal:  Ann R Coll Surg Engl       Date:  2008-07       Impact factor: 1.891

7.  Referral patterns, cancer diagnoses, and waiting times after introduction of two week wait rule for breast cancer: prospective cohort study.

Authors:  Shelley Potter; Sasi Govindarajulu; Mike Shere; Fiona Braddon; Geoffrey Curran; Rosemary Greenwood; Ajay K Sahu; Simon J Cawthorn
Journal:  BMJ       Date:  2007-07-13

8.  Impact of the first surge of the COVID-19 pandemic on a tertiary referral centre for kidney cancer.

Authors:  Teele Kuusk; David Cullen; Joana Briosa Neves; Nicholas Campain; Ravi Barod; Ekaterini Boleti; Soha El-Sheihk; Lee Grant; John Kelly; Marta Marchetti; Faiz Mumtaz; Prasad Patki; Navin Ramachandran; Pedro Silva; My-Anh Tran-Dang; Miles Walkden; Maxine G B Tran; Thomas Powles; Axel Bex
Journal:  BJU Int       Date:  2021-05-25       Impact factor: 5.969

9.  The Patient Deficit Model Overturned: a qualitative study of patients' perceptions of invitation to participate in a randomized controlled trial comparing selective bladder preservation against surgery in muscle invasive bladder cancer (SPARE, CRUK/07/011).

Authors:  Clare Moynihan; Rebecca Lewis; Emma Hall; Emma Jones; Alison Birtle; Robert Huddart
Journal:  Trials       Date:  2012-11-29       Impact factor: 2.279

10.  Design of a multicentre randomized trial to evaluate CT colonography versus colonoscopy or barium enema for diagnosis of colonic cancer in older symptomatic patients: the SIGGAR study.

Authors:  Steve Halligan; Richard J Lilford; Jane Wardle; Dion Morton; Pauline Rogers; Katherine Wooldrage; Rob Edwards; Reshma Kanani; Urvi Shah; Wendy Atkin
Journal:  Trials       Date:  2007-10-27       Impact factor: 2.279

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.